WHO director Tedros Adhanom Ghebreyesus visitng Afrigen's facility in Cape Town, where researchers are working on replicating Moderna's shot (Shelley Christians/Reuters via Alamy)
March 9, 2022 07:14 AM ESTUpdated 09:32 AM
Coronavirus

Mod­er­na’s new patent pol­i­cy is a mixed bless­ing for WHO ef­fort to repli­cate com­pa­ny's vac­cine

Jason Mast

Editor

Mod­er­na’s an­nounce­ment yes­ter­day of a new patent en­force­ment pol­i­cy was glob­al, but it had its most im­me­di­ate im­pact on one small cor­ner of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times